(Q44346805)

2 December 2017

title

No evidence for opioid-mediated analgesia induced by phobic fear (English)

1 reference

2 December 2017

Janssen SA

1

1 reference

2 December 2017

Arntz A

series ordinal

2

1 reference

2 December 2017

publication date

1 September 1997

1 reference

Behaviour Research and Therapy

2 December 2017

published in

1 reference

2 December 2017

volume

35

1 reference

2 December 2017

issue

9

1 reference

2 December 2017

page(s)

823-830

1 reference

Can anxiety help us tolerate pain?

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2897%2900046-6

Anxiety, attention and pain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2897%2900046-6

The influence of anxiety on pain: attentional and attributional mediators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2897%2900046-6

Attention, not anxiety, influences pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2897%2900046-6

Naloxone alters pain perception and somatosensory evoked potentials in normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2897%2900046-6

Psychological control of acute pain in medical settings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2897%2900046-6

Anxiety and pain: attentional and endorphinergic influences.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2897%2900046-6

Naloxone dose dependently produces analgesia and hyperalgesia in postoperative pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2897%2900046-6

Brief standard self-rating for phobic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2897%2900046-6

Recruitment time of conditioned opioid analgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2897%2900046-6

Naloxone-reversible analgesic response to combat-related stimuli in posttraumatic stress disorder. A pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2897%2900046-6

Naloxone does not alter the perception of pain induced by electrical and thermal stimulation of the skin in healthy humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2897%2900046-6

The effect of phobic anxiety on plasma beta-endorphin: a single-subject experiment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2897%2900046-6

Relevant and irrelevant anxiety in the reaction to pain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2897%2900046-6

Electrophysiological evidence for a release of endogenous opiates in stress-induced'analgesia' in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2897%2900046-6

Somatovegetative changes in stress-induced analgesia in man: an electrophysiological and pharmacological study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2897%2900046-6

Opioid antagonist affects behavioral effects of exposure in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2897%2900046-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Opioid antagonist impedes exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2897%2900046-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0005-7967(97)00046-6

1 reference

2 December 2017

1 reference